Bucromarone

This classification denotes an antiarrhythmic agent with the molecular formula C29H37NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JI688O846T, chemically known as 4h-1-benzopyran-4-one, 2-(4-(3-(dibutylamino)propoxy)-3,5-dimethylbenzoyl)- but generally known as bucromarone, which bears US NIH Compound Identifier 132852. European Medicines Agency schedules Bucromarone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05953MIG. The term BUCROMARONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). BUCROMARONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bucromarone under HS 29329985 and SITC 51569. As of Q4 2014, BUCROMARONE remains the US FDA Preferred Term for this commodity. Bucromarone bears US NLM identifiers UMLS ID C0054198 and NCI Concept Code C72577. SMILES: O(CCCN(CCCC)CCCC)C1C(CC(CC1C)C(=O)C1OC2C(C(=O)C1)CCCC2)C.